High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2)

被引:7
作者
LeSarge, Jordan C. [1 ]
Thibeault, Pierre [2 ]
Milne, Mark [5 ]
Ramachandran, Rithwik [2 ]
Luyt, Leonard G. [1 ,3 ,4 ,5 ]
机构
[1] Univ Western Ontario, Dept Chem, 1151 Richmond St, London, ON N6A 3K7, Canada
[2] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 3K7, Canada
[3] Univ Western Ontario, Dept Oncol, 1151 Richmond St, London, ON N6A 3K7, Canada
[4] Univ Western Ontario, Dept Med Imaging, 1151 Richmond St, London, ON N6A 3K7, Canada
[5] Lawson Hlth Res Inst, London Reg Canc Program, 800 Commissioners Rd East, London, ON N6A 5W9, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
Proteinase-activated receptor 2 (PAR2); peptide; targeted fluorescent probes; fluorescence imaging; structure-activity relationship; MOLECULAR-CLONING; EXPRESSION; POTENT; BINDING; PROTEASE-ACTIVATED-RECEPTOR-1; 2-FUROYL-LIGRLO-AMIDE; AGONISTS; PEPTIDE; GROWTH; CANCER;
D O I
10.1021/acsmedchemlett.9b00094
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
PAR2 is a proteolytically activated G protein coupled receptor (GPCR) that is implicated in various cancers and inflammatory diseases. Ligands with low nano molar affinity for PAR2 have been developed, but there is a paucity of research on the development of PAR2-targeting imaging probes. Here, we report the development of seven novel PAR2-targeting compounds. Four of these compounds are highly potent and selective PAR2-targeting peptides (EC50 = 10 to 23 nM) that have a primary amine handle available for facile conjugation to various imaging components. We describe a peptide of the sequence Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 as the most potent and highest affinity PAR2-selective fluorescent probe reported to date (EC50 = 16 nM, K-D = 38 nM). This compound has a greater than 10-fold increase in potency and binding affinity for PAR2 compared to the leading previously reported probe and is conjugated to a red-shifted fluorophore, enabling in vitro and in vivo studies.
引用
收藏
页码:1045 / 1050
页数:11
相关论文
共 38 条
[1]   Structure, function and pathophysiology of protease activated receptors [J].
Adams, Mark N. ;
Ramachandran, Rithwik ;
Yau, Mei-Kwan ;
Suen, Jacky Y. ;
Fairlie, David P. ;
Hollenberg, Morley D. ;
Hooper, John D. .
PHARMACOLOGY & THERAPEUTICS, 2011, 130 (03) :248-282
[2]  
Al-Ani B, 1999, J PHARMACOL EXP THER, V290, P753
[3]   DETECTION OF FUNCTIONAL RECEPTORS FOR THE PROTEINASE-ACTIVATED-RECEPTOR-2-ACTIVATING POLYPEPTIDE, SLIGRL-NH2, IN RAT VASCULAR AND GASTRIC SMOOTH-MUSCLE [J].
ALANI, B ;
SAIFEDDINE, M ;
HOLLENBERG, MD .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (08) :1203-1207
[4]   Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma [J].
Amen, Murasaki ;
Ohishi, Yoshihiro ;
Imamura, Hiroko ;
Shinozaki, Tomoko ;
Yasutake, Nobuko ;
Kato, Kiyoko ;
Oda, Yoshinao .
HUMAN PATHOLOGY, 2017, 64 :156-163
[5]   Protease-Activated Receptor 2 Deficiency Reduces Cardiac Ischemia/Reperfusion Injury [J].
Antoniak, Silvio ;
Rojas, Mauricio ;
Spring, Denise ;
Bullard, Tara A. ;
Verrier, Edward D. ;
Blaxall, Burns C. ;
Mackman, Nigel ;
Pawlinski, Rafal .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (11) :2136-2142
[6]   A refined agonist pharmacophore for protease activated receptor 2 [J].
Barry, Grant D. ;
Suen, Jacky Y. ;
Low, Heng Boon ;
Pfeiffer, Bernhard ;
Flanagan, Bernadine ;
Halili, Maria ;
Le, Giang T. ;
Fairlie, David P. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (20) :5552-5557
[7]   Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1,-2, and-4) in prostate cancer [J].
Black, Peter C. ;
Mize, Gregory J. ;
Karlin, Peter ;
Greenberg, Daniel L. ;
Hawley, Sarah J. ;
True, Lawrence D. ;
Vessella, Robert L. ;
Takayama, Thomas K. .
PROSTATE, 2007, 67 (07) :743-756
[8]  
Bohm SK, 1996, BIOCHEM J, V314, P1009
[9]   Potent Agonists of the Protease Activated Receptor 2 (PAR2) [J].
Boitano, Scott ;
Flynn, Andrea N. ;
Schulz, Stephanie M. ;
Hoffman, Justin ;
Price, Theodore J. ;
Vagner, Josef .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (05) :1308-1313
[10]   Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation [J].
Caruso, Roberta ;
Pallone, Francesco ;
Fina, Daniele ;
Gioia, Valentina ;
Peluso, Ilaria ;
Caprioli, Flavio ;
Stolfi, Carmine ;
Perfetti, Alessandra ;
Spagnoli, Luigi Giusto ;
Palmieri, Giampiero ;
MacDonald, Thomas T. ;
Monteleone, Giovanni .
AMERICAN JOURNAL OF PATHOLOGY, 2006, 169 (01) :268-278